| in vitro susceptibilities of bloodstream isolates of candida species to six antifungal agents: results from a population-based active surveillance programme, barcelona, spain, 2002-2003. | the antifungal drug susceptibilities of 351 isolates of candida species, obtained through active laboratory-based surveillance in the period january 2002-december 2003, were determined (candida albicans 51%, candida parapsilosis 23%, candida tropicalis 10%, candida glabrata 9%, candida krusei 4%). | 2004 | 15618284 |
| [changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in spain: results from the fungemyca study]. | recent epidemiological surveillance studies have reported an increase in fungaemia caused by non-candida albicans species, as well as a decrease in fluconazole susceptibility. | 2011 | 21376831 |
| prevalence of candida bracarensis and candida nivariensis in a spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia. | two new species related to candida glabrata, i.e., candida nivariensis and candida bracarensis, have been proposed. the occurrence of these species among isolates collected in a spanish mycology reference laboratory in 2008-2009 was reviewed. in addition, strains recovered as part of an active population-based surveillance of candidemia conducted in barcelona between 2002 and 2003 were also analyzed. among 143 clinical isolates received in 2008-2009, three (2%) were identified as c. bracarensis ... | 2011 | 21198347 |
| predictors of candidaemia caused by non-albicans candida species: results of a population-based surveillance in barcelona, spain. | although candida albicans (ca) is the most common cause of candida bloodstream infections (bsis), recent studies have observed an increasing percentage of candidaemias caused by non-albicans candida species (nac). in the present study, we attempted to identify the predictors of candidaemia due to nac compared to ca. we analyzed data from an active population-based surveillance in barcelona (spain) from january 2002 to december 2003. factors associated with nac fungaemia were determined by multiv ... | 2010 | 20219079 |
| epidemiology and predictors of mortality in cases of candida bloodstream infection: results from population-based surveillance, barcelona, spain, from 2002 to 2003. | we conducted population-based surveillance for candida bloodstream infections in spain to determine its incidence, the extent of antifungal resistance, and risk factors for mortality. a case was defined as the first positive blood culture for any candida spp. in a resident of barcelona, from 1 january 2002 to 31 december 2003. we defined early mortality as occurring between days 3 to 7 after candidemia and late mortality as occurring between days 8 to 30. we detected 345 cases of candidemia, for ... | 2005 | 15815004 |
| [in vitro sensitivity to 5-fluorocytosine and amphotericin b of yeasts of the candida genus isolated in barcelona]. | in 200 strains of candida sp, 38.5% were found to have intermediate sensitivity or to be resistant to amphotericin b and/or 5-fluorocytosine by the agar diffusion method. when the minimal inhibitory concentrations of these strains were measured, only 7.8% were resistant to amphotericin b and 2.8% to 5-fluorocytosine. the species with the highest levels of resistance were c. parapsilosis, c. tropicalis and torulopsis glabrata. candida albicans did not show resistance to 5-fluorocytosine. | 1990 | 2098147 |